title: Hyperglycemic Ins2AkitaLdlr⁻/⁻ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease.
abstract: Accelerated atherosclerosis is the leading cause of death in type 1 diabetes, but the mechanism of type 1 diabetes-accelerated atherosclerosis is not well understood, in part due to the lack of a good animal model for the long-term studies required. In an attempt to create a model for studying diabetic macrovascular disease, we have generated type 1 diabetic Akita mice lacking the low density lipoprotein receptor (Ins2(Akita)Ldlr⁻/⁻). Ins2(Akita)Ldlr⁻/⁻ mice were severely hyperglycemic with impaired glucose tolerance. Compared with Ldlr⁻/⁻ mice, 20-week-old Ins2(Akita)Ldlr⁻/⁻ mice fed a 0.02% cholesterol AIN76a diet showed increased plasma triglyceride and cholesterol levels, and increased aortic root cross-sectional atherosclerotic lesion area [224% (P < 0.001) in males and 30% (P < 0.05) in females]. Microarray and quantitative PCR analyses of livers from Ins2(Akita)Ldlr⁻/⁻ mice revealed altered expression of lipid homeostatic genes, including sterol-regulatory element binding protein (Srebp)1, liver X receptor (Lxr)α, Abca1, Cyp7b1, Cyp27a1, and Lpl, along with increased expression of pro-inflammatory cytokine genes, including interleukin (Il)1α, Il1β, Il2, tumor necrosis factor (Tnf)α, and Mcp1. Immunofluorescence staining showed that the expression levels of Mcp1, Tnfα, and Il1β were also increased in the atherosclerotic lesions and artery walls of Ins2(Akita)Ldlr⁻/⁻ mice. Thus, the Ins2(Akita)Ldlr⁻/⁻ mouse appears to be a promising model for mechanistic studies of type 1 diabetes-accelerated atherosclerosis.
authors: Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, NY, USA.
authors: Changcheng
authors: C
authors: Zhou
authors: Brian
authors: B
authors: Pridgen
authors: Nakesha
authors: N
authors: King
authors: Jinxian
authors: J
authors: Xu
authors: Jan L
authors: JL
authors: Breslow
references: J Clin Invest. 1995 Aug;96(2):976-86
references: 7635990
references: Biol Chem. 2005 Nov;386(11):1077-85
references: 16307473
references: Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):139-43
references: 19797709
references: J Lipid Res. 2007 Feb;48(2):299-306
references: 17079792
references: Diabetes. 2008 Nov;57(11):2924-32
references: 18678617
references: Am J Cardiol. 1987 Apr 1;59(8):750-5
references: 3825934
references: Cell. 2006 Jan 13;124(1):35-46
references: 16413480
references: Diabetologia. 2003 Jun;46(6):760-5
references: 12774166
references: Diabetes. 2006 Sep;55(9):2502-9
references: 16936198
references: Science. 1993 Jan 1;259(5091):87-91
references: 7678183
references: Endocr Rev. 2001 Feb;22(1):36-52
references: 11159815
references: Bioinformatics. 2007 Dec 1;23(23):3251-3
references: 17644558
references: Diabetes. 2003 Feb;52(2):409-16
references: 12540615
references: Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1513-8
references: 20631351
references: Mol Cell. 1998 Aug;2(2):275-81
references: 9734366
references: Nature. 2005 Oct 13;437(7061):1032-7
references: 16136080
references: Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1907-13
references: 12907460
references: J Lipid Res. 2009 Oct;50(10):2004-13
references: 19436068
references: Drugs. 2007;67(7):997-1026
references: 17488145
references: Circulation. 2005 Jun 28;111(25):3489-93
references: 15983263
references: Lancet. 2008 May 24;371(9626):1790-9
references: 18502304
references: Nat Rev Immunol. 2006 Jul;6(7):508-19
references: 16778830
references: Diabetes Care. 2006 Nov;29(11):2528-38
references: 17065698
references: Mutat Res. 2002 Dec;512(2-3):121-34
references: 12464347
references: J Clin Invest. 2006 Mar;116(3):607-14
references: 16511593
references: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10261-6
references: 9294198
references: Circ Res. 2007 May 25;100(10):1415-27
references: 17525381
references: J Lipid Res. 2007 Feb;48(2):373-84
references: 17088262
references: Funct Integr Genomics. 2007 Jul;7(3):193-205
references: 17186197
references: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references: 16199517
references: Nature. 2000 Sep 14;407(6801):233-41
references: 11001066
references: Science. 1996 May 3;272(5262):685-8
references: 8614828
references: Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1693-701
references: 16763160
references: BMC Genomics. 2010 Dec 20;11:722
references: 21172007
references: J Clin Invest. 1998 May 15;101(10):2112-8
references: 9593767
references: J Clin Invest. 1995 Dec;96(6):2555-68
references: 8675619
references: Nature. 2002 Dec 19-26;420(6917):868-74
references: 12490960
references: J Biol Chem. 2000 Jun 2;275(22):16536-42
references: 10748048
references: J Biol Chem. 1991 Apr 25;266(12):7779-83
references: 2019602
references: Diabetes Care. 2005 Sep;28(9):2130-5
references: 16123478
references: J Clin Invest. 1998 Sep 1;102(5):893-901
references: 9727057
references: J Clin Invest. 1999 Jan;103(1):27-37
references: 9884331
references: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7522-7
references: 11390966
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: J Clin Invest. 2007 Aug;117(8):2337-46
references: 17657314
references: Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):742-8
references: 20110573